- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Larazotide acetate (AT1001) is a Zonulin receptor antagonist, a tight junction modulator. Larazotide inhibition of zonulin results in reducing trafficking across epithelial cells in the intestines and reducing intestinal permeability and "leaky gut," thought to be a gateway to multiple autoimmune diseases, including celiac disease, irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD, Crohn′s and ulcerative colitis), type 1 diabetes mellitus (T1DM), nonalcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and several others. It has been shown to inhibit the effect of inflammatory cytokines such as tumor necrosis factor (TNF-alpha) and interleukin (IL-4), blocking their increase of intestinal epithelial permeability.
Zonulin receptor antagonist; tight junction modulator
| assay | ≥95% (HPLC) |
| form | powder |
| color | white to beige |
| shipped in | wet ice |
| storage temp. | −20°C |
| SMILES string | N1([C@@H](CCC1)C(=O)NCC(=O)O)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)CC(C)C)C(C)C)CCC(=O)N.OC(=O)C |
| InChI | 1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)( |
| InChI key | NYGCNONRVCGHAT-UFIKZEAMSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 4164.19
-
询价
-
询价
-
¥ 2019.57
-
询价
-
询价
-
询价
-
¥ 1956.41
-
¥ 8135.09
-
询价
-
¥ 3812.28
-
询价
-
¥ 3319.60
-
¥ 2666.57
-
¥ 2307.00
-
¥ 9909.51
-
¥ 3796.67
-
询价
-
¥ 26846.31
微信小程序
7X24小时在线咨询